Read the full release here >>><\/a><\/p>\n PCR for the detection of spoilage organisms in beverages<\/p>\n To support the quality of beverage products, Thermo Fisher Scientific<\/a> (MA, USA) has introduced the Thermo Scientific\u2122 SureTect\u2122 Beverage Spoilage Multiplex qPCR Assay, an industry-first all-in-one quantitative PCR-based test developed in collaboration with Coca-Cola Europacific Partners. Now part of the Thermo Scientific SureTect PCR System, the assay offers early and accurate detection of spoilage organisms earlier in the production process and has wide applicability across the beverage testing industry.<\/p>\n Read the full release here >>><\/a><\/p>\n Next-generation nucleic acid purification<\/p>\n Primerdesign<\/a> (Manchester, UK), a company focused on the design, manufacture, validation and supply of real-time PCR kits and reagents, has announced the launch of its exsig\u00ae Mag RapidBead Pro Extraction kit. The next-generation magnetic bead-based kit can be used to extract high-quality DNA and RNA from diverse sample types. The streamlined and adaptable protocol enables efficient nucleic acid purification without compromising on yield and purity.<\/p>\n Read the full release here >>><\/a><\/p>\n In this interview, Namshik Han \u2013 Professor at\u00a0Yonsei University\u00a0and leader of the AI discovery group in the Milner Institute at the University of Cambridge \u2013 explains quantum algorithms with a London Tube analogy, how they can be applied to benefit drug discovery, and shares his advice for researchers wanting to launch their own startups.<\/p>\n Partnerships Agilent Technologies Inc.<\/a> (CA, USA) announced the signing of a five-year Memorandum of Understanding with National Heart Centre Singapore<\/a> (NHCS) to accelerate innovation in metabolic heart failure research, one of the most complex and underserved areas in cardiovascular medicine. Under this agreement, Agilent and NHCS will combine their expertise in human cardiac organoids using human-derived heart tissues with cutting-edge analytical technologies, including Agilent\u2019s latest\u00a0Seahorse XF Flex Analyzer<\/a>,\u00a0which expands real-time metabolic analysis into 3D tissues and organoid workflows to investigate metabolic drivers of heart failure.<\/p>\n Read the full release here >>><\/a><\/p>\n Partnering for AI-designed bispecific binding proteins<\/p>\n Bio-Techne Corporation<\/a> (MN, USA), a provider of life science tools, reagents and diagnostic products, has announced a licensing agreement with\u00a0Monod Bio<\/a> (WA, USA), a biotechnology company spun out from the Nobel Prize-winning David Baker lab<\/a> at the University of Washington, Institute for Protein Design<\/a> (WA, USA). The agreement grants Bio-Techne exclusive commercial rights to a specific subset of Monod\u2019s NovoBody\u2122 Duo molecules, a new class of AI-designed bispecific binding proteins.<\/p>\n Read the full release here >>><\/a><\/p>\n Sponsoring the Microbes in Wastewater Symposium 2026<\/p>\n Zymo Research Corporation<\/a> (CA, USA), a molecular biology and pathogen detection company, is sponsoring the Microbes in Wastewater Symposium 2026, taking place 15\u201316 January 2026 at the Balboa Bay Resort in Newport Beach (CA, USA). The annual event brings together leading researchers, government agencies and industry partners to advance scientific understanding and collaboration in wastewater-based epidemiology and microbial surveillance.<\/p>\n Read the full release here >>><\/a><\/p>\n We sat down with Heather Pinkett \u2013 Professor in the Department of Molecular Biosciences at\u00a0Northwestern University\u00a0and President of The Protein Society \u2013 to learn more about ABC transporters and what targeting them could mean for combatting antimicrobial resistance.<\/p>\n Publications and webinars In recognition of antimicrobial resistance (AMR) week, observed from 18\u201324 November every year, Illumina<\/a> (CA, USA) shared an article highlighting how their technology is facilitating breakthroughs in the fight against AMR.<\/p>\n Armed with Illumina whole-genome sequencing (WGS) technology, next-generation sequencing (NGS) technology and library prep kits, scientists can better inform AMR reduction strategies. WGS and NGS tools detect and characterize pathogens and AMR genes and markers, enabling health care systems to predict phenotype resistance, monitor patterns of resistance, and rapidly detect it. Microbial genomic data also helps researchers gain insight into the efficacy of antimicrobial drugs, informing the development of new medications to help improve patient care.<\/p>\n Read the full article here >>><\/a><\/p>\n Seamlessly integrate next-generation large-particle assays into your flow cytometry workflows<\/p>\n Advances in cell therapy, cancer biology, and immunology increasingly require analytical tools that can accommodate complex models and functional assays. Emerging applications involving large cells, aggregates, and \u201clab-on-a-particle\u201d platforms demand reliable characterization and sorting of these samples. Conventional flow cytometers have challenges with larger particles such as clogging, low sort efficiency and reduced recovery.<\/p>\n In an upcoming webinar, Sony Biotechnology<\/a> (CA, USA) will introduce the new Large Particle Sorting Upgrade for the SH800 and MA900 Cell Sorters, designed to expand compatibility with large and\/or structurally complex sample types. Learn how this new capability enables researchers to seamlessly integrate next-generation large-particle assays into routine flow cytometry workflows.<\/p>\n Register here >>><\/a><\/p>\n Advances in antibody discovery<\/p>\n Antibodies play a central role in modern medicine, serving as both therapeutics and as essential tools in diagnostics. While antibody generation against soluble proteins is well established, discovering binders to complex, multipass membrane proteins such as G-protein\u2013coupled receptors (GPCRs) remains one of the greatest technical challenges in the field.<\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2025\/11\/Namshik-Han-header-image-300x129.png\")
Quantum questions have algorithmic answers: navigating a drug discovery network<\/a><\/p>\n
\nAccelerating innovation in metabolic heart failure research<\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2025\/11\/Heather-Pinkett-interview-header-300x129.png\")
Targeting ABC to tackle AMR: taking advantage of bacterial membrane proteins<\/a><\/p>\n
\nThe sequencing technology informing antimicrobial resistance reduction strategies<\/p>\n